Precision targeted therapy of ovarian cancerTumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapyDendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.Antibodies and peptides in cancer therapy.Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment.Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsInhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexesNanotechnology approaches for inhalation treatment of fibrosis.Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer.Drug targeting to the colon with lectins and neoglycoconjugates.Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.Remediation of cellular hypoxic damage by pharmacological agents.New generation of liposomal drugs for cancer.Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNAPluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsShape effects of filaments versus spherical particles in flow and drug delivery.Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkageGenotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance.Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention.Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.Nanotechnology approaches for personalized treatment of multidrug resistant cancers.Soluble polymer conjugates for drug delivery.Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis.Nanotechnology approaches for inhalation treatment of lung diseases.Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value.LHRH-Targeted Drug Delivery Systems for Cancer Therapy.A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts.Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer.
P50
Q28078658-A42FB902-E4E9-400A-85D2-79C6E9C977CCQ30830508-980807EA-C8B9-42EB-93AB-D15643C75754Q33263562-A9E5B066-6A93-48F7-9E08-091C1EF961F1Q33281676-199E2843-B995-4309-9686-69F8163A8405Q33292710-ECCD0EFD-5080-4DDC-B521-1C398FC72917Q33708231-48C994CC-917E-4818-A24B-711CC542C9B8Q33934763-895A69AF-FDE5-4436-A58B-A52355A5B7EEQ34058107-A314CD21-6740-463B-9C05-E198D8D9C6B1Q34449624-834330F5-39DC-44ED-BDFA-AD3687F322EFQ34464430-AC1BD0F7-DCB1-4D9D-82A9-F260C59C68E7Q34707568-2ACA881A-6D69-466E-B796-8C19CAC32C6FQ35098580-2D548C74-CD52-4AD5-8C12-C882CE893C69Q35669916-878046A5-EBE1-4DAC-8F0D-1AC7B666FE13Q35953437-FD728329-D02F-4B43-92BC-ED06F4BC1CCBQ36070727-72125C94-71D6-4088-B552-D8077915489FQ36264615-E935B6C0-B752-435C-9B3B-406D1716C157Q36651719-228EEDCD-B384-4D76-9437-E3A6D93CD0D1Q36662084-207592B6-516E-44A8-9A3F-39943BF52194Q37067185-D8669AF4-B392-47F6-BEAA-67B9B9E52974Q37121611-93A60CA8-CDA1-4FB8-A016-C616F4FD6E49Q37154296-B01EBFC2-D4E6-4720-9250-2AFF17277685Q37263033-B0FAA870-9450-4576-8984-73F8F80E1C6BQ37338776-D3FAE5E2-AD6A-448C-A160-247B4AE18E0CQ37344480-48F9A05F-7AF9-4513-A5DA-DBF0129536AFQ37356199-863CDF89-8952-4DF9-AE50-56ADD65BEC07Q37376529-0C52E4A4-AB5D-4662-92B3-8B752B06B378Q37505241-F0199A6F-93B9-42F0-A142-0C8BC0D75655Q37652227-B17A164E-A4C9-48BB-B0FA-7D79F936D9B0Q37672440-130539F3-3B7F-44AF-95FC-5CCD3A95609EQ37804902-7062506C-F9C5-418D-91B1-C8084CAFFB96Q38152145-69CFF7F7-EE56-44D7-9937-0D60D9C4F6D5Q38225036-3D7173E7-C6A9-4090-B7B2-E2511982D34EQ38327980-8AE4F63A-8336-48F0-B398-B3ACAA6C883EQ38571420-364DE3A8-1963-4981-9DDB-40661207B67EQ38824212-DF09142D-9107-43E9-92FE-7F75C5FF0E47Q38884960-00BB3804-DCE1-49AF-8809-BEBC25F83CDBQ38980206-C846F21D-1915-4580-B9B6-04D9AB91A1EEQ39012792-E6A88520-392A-4D2D-BBC9-04B691053198Q39430827-EDB05CBA-2630-4F4A-84B4-A19C410A7946Q39443396-DA8A8FB9-B4A5-4323-B0DA-82D73E4DEE04
P50
description
Herausgeberin
@de
editora ucraina
@ast
pharmaceutical researcher
@en
профессор фармацевтики
@ru
name
Tamara Minko
@ast
Tamara Minko
@ca
Tamara Minko
@de
Tamara Minko
@en
Tamara Minko
@es
Tamara Minko
@fr
Tamara Minko
@nl
Tamara Minko
@sl
Tamara Minko
@sq
Тамара Минко
@ru
type
label
Tamara Minko
@ast
Tamara Minko
@ca
Tamara Minko
@de
Tamara Minko
@en
Tamara Minko
@es
Tamara Minko
@fr
Tamara Minko
@nl
Tamara Minko
@sl
Tamara Minko
@sq
Тамара Минко
@ru
altLabel
Minko T
@en
Minko T.
@en
Minko
@en
T Minko
@en
T. Minko
@en
prefLabel
Tamara Minko
@ast
Tamara Minko
@ca
Tamara Minko
@de
Tamara Minko
@en
Tamara Minko
@es
Tamara Minko
@fr
Tamara Minko
@nl
Tamara Minko
@sl
Tamara Minko
@sq
Тамара Минко
@ru